Literature DB >> 22528954

Lipid peroxidation and paraoxonase activity in nocturnal cyclic and sustained intermittent hypoxia.

Hacer Kuzu Okur1, Zerrin Pelin, Meral Yuksel, Sebnem Yosunkaya.   

Abstract

PURPOSE: Obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD) have been known to be associated with atherosclerosis and hypoxia which was suggested to have an important role in this process by the way of increased oxidative stress. In the present study, we aimed to evaluate the effects of nocturnal hypoxia pattern (intermittent versus sustained) on serum lipid peroxidation and paraoxonase (PON) activity.
METHODS: Blood collections were performed in 44 OSA, 11 non-apneic, nocturnal desaturated COPD, and 14 simple snorer patients after full-night polysomnographic recordings. Nocturnal sleep and respiratory parameters, oxygen desaturation indexes, serum malondialdehyde (MDA) levels by measuring with the help of the formation of thiobarbituric acid reactive substances (TBARS), and PON activity were assessed in all subjects.
RESULTS: OSA and COPD patients showed nocturnal hypoxemia, with a minimum oxygen saturation (SaO(2)) in ranges of 53-92 % and 50-87 %, respectively. The mean levels of TBARS was 15.7 ± 3.6 nmol and 15.3 ± 3.4 nmol malondialdehyde (MDA)/ml in OSA and COPD patients, respectively, while the mean level of the control group was 4.1 ± 1.2 nmol MDA/ml. The mean PON activity was found to be 124.2 ± 35.5 U/l in OSA patients and 124.6 ± 28.4 U/l in COPD patients. The mean PON activity of the control group was 269.0 ± 135.8 U/l. The increase in TBARS levels and the decrease in PON1 levels were statistically significant in both OSA and COPD patients according to controls (p < 0.001 for TBARS as well as PON1).
CONCLUSION: The results of this study revealed that both OSA and non-apneic, nocturnal desaturated COPD patients showed increased levels of lipid peroxidation and decreased PON activity despite the differences in nocturnal hypoxia pattern.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528954     DOI: 10.1007/s11325-012-0703-5

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  48 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation.

Authors:  Ivana Stanojkovic; Jelena Kotur-Stevuljevic; Branislava Milenkovic; Slavica Spasic; Tatjana Vujic; Aleksandra Stefanovic; Aleksandra Llic; Jasmina Ivanisevic
Journal:  Respir Med       Date:  2011-10       Impact factor: 3.415

3.  Stretch force on vascular smooth muscle cells enhances oxidation of LDL via superoxide production.

Authors:  N Inoue; S Kawashima; K I Hirata; Y Rikitake; S Takeshita; W Yamochi; H Akita; M Yokoyama
Journal:  Am J Physiol       Date:  1998-06

Review 4.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

5.  Assay for blood plasma or serum.

Authors:  K Yagi
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

6.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Authors:  M Aviram; M Rosenblat; C L Bisgaier; R S Newton; S L Primo-Parmo; B N La Du
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

7.  Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study.

Authors:  D J Hole; G C Watt; G Davey-Smith; C L Hart; C R Gillis; V M Hawthorne
Journal:  BMJ       Date:  1996-09-21

8.  Nocturnal oxyhemoglobin desaturation in COPD patients with arterial oxygen tensions above 60 mm Hg.

Authors:  E C Fletcher; J Miller; G W Divine; J G Fletcher; T Miller
Journal:  Chest       Date:  1987-10       Impact factor: 9.410

9.  Relationship between obesity and serum markers of oxidative stress and inflammation in Japanese.

Authors:  Koji Suzuki; Yoshinori Ito; Junichi Ochiai; Yasuhiro Kusuhara; Shuji Hashimoto; Shinkan Tokudome; Masayo Kojima; Kenji Wakai; Hideaki Toyoshima; Koji Tamakoshi; Yoshiyuki Watanabe; Norihiko Hayakawa; Morito Maruta; Makoto Watanabe; Kazuo Kato; Yoshiji Ohta; Akiko Tamakoshi
Journal:  Asian Pac J Cancer Prev       Date:  2003 Jul-Sep

10.  Evidence for lipid peroxidation in obstructive sleep apnea.

Authors:  Lena Lavie; Alona Vishnevsky; Peretz Lavie
Journal:  Sleep       Date:  2004-02-01       Impact factor: 5.849

View more
  8 in total

Review 1.  [Chronic hypoxia and cardiovascular risk : Clinical significance of different forms of hypoxia].

Authors:  U Koehler; O Hildebrandt; J Krönig; W Grimm; J Otto; W Hildebrandt; R Kinscherf
Journal:  Herz       Date:  2017-05-04       Impact factor: 1.443

2.  Circulating Anti-Coatomer Protein Complex Subunit Epsilon (COPE) Autoantibodies as a Potential Biomarker for Cardiovascular and Cerebrovascular Events in Patients with Obstructive Sleep Apnea.

Authors:  Takuma Matsumura; Jiro Terada; Taku Kinoshita; Yoriko Sakurai; Misuzu Yahaba; Ryogo Ema; Atsuko Amata; Seiichiro Sakao; Kengo Nagashima; Koichiro Tatsumi; Takaki Hiwasa
Journal:  J Clin Sleep Med       Date:  2017-03-15       Impact factor: 4.062

3.  Peripheral blood oxidative stress markers for obstructive sleep apnea-a meta-analysis.

Authors:  Yuzhui Hu; Lin Mai; Jingying Luo; Wensong Shi; Hui Xiang; Sijia Song; Liuyan Hong; Wenting Long; Biwen Mo; Miao Luo
Journal:  Sleep Breath       Date:  2022-01-03       Impact factor: 2.816

Review 4.  Paraoxonase-1 Concentrations in Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis.

Authors:  Maria Carmina Pau; Angelo Zinellu; Elisabetta Zinellu; Gianfranco Pintus; Ciriaco Carru; Alessandro G Fois; Arduino A Mangoni; Pietro Pirina
Journal:  Antioxidants (Basel)       Date:  2022-04-12

Review 5.  Biomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: current status and future perspectives.

Authors:  Konstantinos Archontogeorgis; Evangelia Nena; Nikolaos Papanas; Paschalis Steiropoulos
Journal:  Pulm Med       Date:  2014-11-27

6.  Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease.

Authors:  Gianna Camiciottoli; Francesca Bigazzi; Chiara Magni; Viola Bonti; Stefano Diciotti; Maurizio Bartolucci; Mario Mascalchi; Massimo Pistolesi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-09-14

Review 7.  Paraoxonase 1 and Chronic Obstructive Pulmonary Disease: A Meta-Analysis.

Authors:  Jun Watanabe; Kazuhiko Kotani; Alejandro Gugliucci
Journal:  Antioxidants (Basel)       Date:  2021-11-26

Review 8.  Circulating Malondialdehyde Concentrations in Obstructive Sleep Apnea (OSA): A Systematic Review and Meta-Analysis with Meta-Regression.

Authors:  Maria Carmina Pau; Elisabetta Zinellu; Sara S Fois; Barbara Piras; Gianfranco Pintus; Ciriaco Carru; Arduino A Mangoni; Alessandro G Fois; Angelo Zinellu; Pietro Pirina
Journal:  Antioxidants (Basel)       Date:  2021-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.